Entering text into the input field will update the search result below

ENZ, DLKM, PAR, DHT, PDS - Stock Updates! from CRWEfinance.com

Jan. 04, 2011 12:34 PM ET
Lynnai profile picture
Lynnai's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.




PAR Technology Corp. (NYSE:PAR) announced that it has changed the ticker symbol of its shares on the New York Stock Exchange from "PTC" to "PAR," and was effective at the start of trading yesterday, Monday, January 3, 2011. In so doing, PAR aligns its ticker symbol with the name that is consistent with its industry recognition and reinforces the company's 42-year brand. Commenting on the new symbol, PAR Technology Chairman and CEO John W. Sammon said, “We are pleased to have obtained our new ticker symbol, “PAR”, one which reflects accurately the name of our organization, is more easily identifiable and is easier to remember.

PAR Technology Corporation provides professional services and enterprise business management technology to the hospitality industry worldwide. The company operates through two segments, Hospitality and Government.


  Enzo Biochem, Inc. (NYSE:ENZ)

Enzo Biochem, Inc. recently announced improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. ENZ operates in three segments: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. The Enzo Life Sciences segment manufactures, develops, and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers. It offers products applied in the fields of antibiotics, autophagy, cancer, cell cycle, cell death, cell signaling, cell trafficking, genomics/molecular biology, immunology, inflammation, lipid signaling, neurobiology, protein degradation, ROS/RNS, and stress/heat shock. The Enzo Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It also operates a full-service clinical laboratory, a network of 30 patient service centers, a stand alone or rapid response laboratory, and a full-service phlebotomy department. The Enzo Therapeutics segment engages in the research and development of various therapeutic drug candidates based on cell signaling, immune regulation, and gene regulation for the treatment of gastrointestinal, infectious, ophthalmic, and metabolic diseases. ENZ sells its products through direct sales force and distributors in the United States, Switzerland, the United Kingdom, Belgium, and Germany. ENZ was founded in 1976 and is headquartered in New York, New York.

To learn more about ENZ visit:  http://www.enzo.com


DHT Holdings, Inc. (NYSE:DHT) announced DHT has acquired a VLCC built 1999 at Daewoo for USD 55.0 Million. The vessel will be delivered during the first quarter of 2011 and will be named DHT Phoenix. The company will finance the acquisition with cash at hand and bank debt and intend to employ the vessel in the Tankers International Pool. this information release contains assumptions, expectations, projections, intentions and beliefs about future events, in particular regarding daily charter rates, vessel utilization, the future number of newbuilding deliveries.

DHT Holdings, Inc., through its subsidiary, DHT Maritime, Inc., operates a fleet of double-hull crude oil tankers. As of March 25, 2010, the company fleet consisted of 3 very large crude carriers.


  Douglas Lake Minerals Inc. (OTC:DLKM)

Douglas Lake Minerals Inc. recently provided an update regarding its recently acquired Handeni Project which is located in the rapidly developing region of eastern Tanzania. Douglas Lakes' 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 km(2) which are directly adjacent to, and partly surround, Canaco Resources Inc's (V.CAN) 200 km(2) Kilindi license which holds the Magambazi gold mineralization occurrence.

Douglas Lake Successfully Delineates Structural Controls on Gold Mineralization in the Four Handeni Project PLs.

Douglas Lake Minerals Inc. offers gold mining and exploration services. DLKM is based in Surrey, Canada.

To learn more about DLKM visit:  http://www.douglaslakeminerals.com


Precision Drilling Corporation (NYSE:PDS) announced that planned capital expenditures for 2011 are $405 million. This includes $119 million for sustaining and infrastructure expenditures and is based upon currently anticipated activity levels for 2011. Additionally, $171 million is slated for expansion capital and includes the cost to complete the remaining five of the nine new rigs previously announced and an anticipated five additional new rig builds for 2011. The total capital expenditures also include the cost to upgrade eight to twelve rigs in 2011 and to purchase long lead time items for the Corporation's inventory at an anticipated cost of $115 million.

Precision Drilling Corporation, through its subsidiaries, provides onshore drilling, well servicing, and ancillary oilfield services to the oil and gas industry primarily in Canada and the United States.




Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.